P Maisonneuve

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. ncbi Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
    P Maisonneuve
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet 354:93-9. 1999
  2. ncbi Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study
    P Maisonneuve
    Division of Epidemiology, European Institute of Oncology, Milan, Italy
    Am J Kidney Dis 35:157-65. 2000
  3. doi Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure
    E Montagna
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 118:385-94. 2009
  4. ncbi Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease
    M Colleoni
    Research Unit in Medical Senology, Department of Medicine, Instituto Europeo di Oncologia, Milan, Italy
    Ann Oncol 17:1497-503. 2006
  5. pmc Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
    C Bosetti
    Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Ann Oncol 23:1880-8. 2012
  6. ncbi Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma
    G Viale
    Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
    Cancer 92:1378-84. 2001
  7. doi Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
    G Cancello
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 21:1974-81. 2010
  8. ncbi Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer
    M Colleoni
    Research Unit in Medical Senology at the Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy
    Ann Oncol 18:1632-40. 2007
  9. doi Outcome of special types of luminal breast cancer
    M Colleoni
    Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 23:1428-36. 2012
  10. ncbi Gestational trophoblastic diseases
    H Y Ngan
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:167-74. 2003

Detail Information

Publications60

  1. ncbi Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
    P Maisonneuve
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet 354:93-9. 1999
    ..The aim of this study was to examine the risk of cancer in a large cohort of patients treated by dialysis but not transplantation...
  2. ncbi Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study
    P Maisonneuve
    Division of Epidemiology, European Institute of Oncology, Milan, Italy
    Am J Kidney Dis 35:157-65. 2000
    ....
  3. doi Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure
    E Montagna
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 118:385-94. 2009
    ..Treatment recommendations for systemic therapy should not take into account the presence of a single micrometastatic lymph node identified during complete serial sectioning of sentinel node(s)...
  4. ncbi Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease
    M Colleoni
    Research Unit in Medical Senology, Department of Medicine, Instituto Europeo di Oncologia, Milan, Italy
    Ann Oncol 17:1497-503. 2006
    ..There is limited knowledge about prognosis, and treatment effects in young women with node-negative disease...
  5. pmc Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
    C Bosetti
    Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Ann Oncol 23:1880-8. 2012
    ..To evaluate the dose-response relationship between cigarette smoking and pancreatic cancer and to examine the effects of temporal variables...
  6. ncbi Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma
    G Viale
    Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
    Cancer 92:1378-84. 2001
    ....
  7. doi Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
    G Cancello
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 21:1974-81. 2010
    ..There is limited knowledge about prognosis of selected breast cancer subtypes among very young women...
  8. ncbi Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer
    M Colleoni
    Research Unit in Medical Senology at the Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy
    Ann Oncol 18:1632-40. 2007
    ..4%), focal (368, 14.1%), moderate (51, 2.0%) and extensive (170, 6.5%)...
  9. doi Outcome of special types of luminal breast cancer
    M Colleoni
    Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 23:1428-36. 2012
    ..The identification of special types of breast cancer might be of value in assessing prognosis and predicting response to therapy...
  10. ncbi Gestational trophoblastic diseases
    H Y Ngan
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:167-74. 2003
  11. ncbi Carcinoma of the Fallopian tube
    A P Heintz
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:119-33. 2003
  12. ncbi Carcinoma of the corpus uteri
    W T Creasman
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:79-118. 2003
  13. ncbi Carcinoma of the cervix uteri
    J L Benedet
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:41-78. 2003
  14. ncbi Carcinoma of the vagina
    U Beller
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:27-39. 2003
  15. ncbi Carcinoma of the ovary
    A P Heintz
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:135-66. 2003
  16. doi Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
    G Cancello
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan 20141, Italy
    Ann Oncol 24:661-8. 2013
    ..The immunohistochemical (IHC) evaluation of estrogen receptor (ER), progesterone receptor (PgR), Ki-67 and HER2 is considered a surrogate means for identifying the molecular subtypes of breast cancer with different prognosis...
  17. doi Nipple sparing mastectomy: can we predict the factors predisposing to necrosis?
    Z K Algaithy
    Division of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Surg Oncol 38:125-9. 2012
    ..This study aimed to analyze the factors that may lead to skin necrosis after NSM...
  18. doi Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    G Cancello
    Unit of Research in Medical Senology, Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 127:713-20. 2011
    ..In conclusion, women with small size, node-negative, breast cancer are at higher risk of relapse if with HER2-positive endocrine receptor absent or Triple Negative disease...
  19. pmc Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)
    E Lucenteforte
    Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri Milan, Milan, Italy
    Ann Oncol 23:374-82. 2012
    ..Heavy alcohol drinking has been related to pancreatic cancer, but the issue is still unsolved...
  20. doi Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis
    S Iodice
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cancer 46:2275-84. 2010
    ..The association between oral contraceptive and BRCA1 or BRCA2 gene mutations carriers is unclear...
  21. ncbi Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments
    S Zurrida
    Senology Department, European Institute of Oncology, Milan, Italy
    Crit Rev Oncol Hematol 38:223-30. 2001
    ..It is too early to assess the significance of this finding...
  22. ncbi Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes
    M Manzotti
    Department of Pathology, European Institute of Oncology, Via Ripmaonti 435, I-20141 Milan, Italy
    Int J Cancer 95:307-12. 2001
    ..4% and 84.6%, respectively). The high prevalence of positive reverse transcription-polymerase chain reaction assays in histologically uninvolved SLNs, however, may hamper extensive application of these techniques in the clinical setting...
  23. pmc Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group
    A Decensi
    FIRC Chemoprovention Unit, European Institute of Oncology, Milan, Italy
    Br J Cancer 78:572-8. 1998
    ..Whereas a trial of tamoxifen in women already on transdermal HRT is warranted, prescription of HRT during tamoxifen may attenuate its activity...
  24. ncbi Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
    P Boyle
    European Institute of Oncology, Milan, Italy
    Ann Oncol 14:1312-25. 2003
    ..A programme of activities and research, focussing on three major themes [prevention (particularly tobacco control), screening, and education and training], was developed together with the European Code Against Cancer...
  25. ncbi Cancer control in women. Update 2003
    P Boyle
    Dept of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Int J Gynaecol Obstet 83:179-202. 2003
    ..Although more work is needed, it is becoming clear that there could be an important role of HPV testing to further enhance cervix cancer screening...
  26. ncbi Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy
    U Veronesi
    Division of Senology, European Institute of Oncology, Via G Ripamonti 435, 20141 Milan, Italy
    Ann Oncol 16:383-8. 2005
    ..The aim of the study was to assess the role of axillary radiotherapy (RT) in reducing axillary metastases in patients with early breast cancer who did not receive axillary dissection...
  27. doi Genomic characterization of asymptomatic CT-detected lung cancers
    E Belloni
    Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
    Oncogene 30:1117-26. 2011
    ....
  28. doi Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis
    S Iodice
    European Institute of Oncology, Milan, Italy
    J Thromb Haemost 6:781-8. 2008
    ..Despite a recognized association between venous thromboembolic events (VTE) and cancer, little is known about the strength and the features of this association. We performed a meta-analysis in order to clarify this issue...
  29. ncbi Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung
    G Pelosi
    Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
    Am J Surg Pathol 25:363-72. 2001
    ..Our findings suggest that TTF-1 could be involved in the development of small pulmonary adenocarcinomas, but it has not prognostic implications in patients with stage I NSCLC...
  30. ncbi Long-term oncological results of breast conservative treatment with oncoplastic surgery
    M Rietjens
    Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
    Breast 16:387-95. 2007
    ..53%). Patients with tumours larger than 2 cm were at greater risk of local recurrences and distant metastasis. Long-term oncologic results of BCT with oncoplastic surgery are comparable with the results of BCT randomized trials...
  31. ncbi Is colonoscopy a suitable investigation in the preoperative staging of ovarian cancer patients?
    D Ravizza
    European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy
    Dig Liver Dis 37:57-61. 2005
    ..During ovarian cancer surgery, colorectal resection may be required. In our institution, preoperative colonoscopy is performed in order to assess visceral involvement...
  32. ncbi Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects
    M Colleoni
    Division of Medical Oncology, University of Milan School of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 17:232-8. 2006
    ..We previously demonstrated efficacy and impact on serum vascular endothelial growth factor (VEGF) for metronomic cyclophosphamide (C) and methotrexate (M) in patients with breast cancer. New metronomic schedules were investigated...
  33. doi Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model
    G Veronesi
    Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy Electronic address
    Lung Cancer 82:426-30. 2013
    ..We assessed outcomes and the predictive ability of the COSMOS prediction model in volunteers screened for 10 years...
  34. doi Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial
    D Serrano
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Pharmacogenomics J 11:100-7. 2011
    ..Conversely, the CYP2D6*2A allele may be associated with increased efficacy of tamoxifen. These findings support the relevance of pharmaco-genomics in tailoring tamoxifen treatment...
  35. pmc Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4)
    P Bertuccio
    Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Ann Oncol 22:1420-6. 2011
    ..Cigarette smoking is the best-characterized risk factor for pancreatic cancer. However, data are limited for other tobacco smoking products and smokeless tobacco...
  36. pmc Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ecancermedicalscience 3:149. 2009
    ..The purpose of this paper is to describe the development of the TR at the European Institute of Oncology (IEO), Milan, Italy, from its origin to its current applications...
  37. ncbi Carcinoma of the vulva
    U Beller
    FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Int J Gynaecol Obstet 83:7-26. 2003
  38. ncbi Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures
    A Cortelezzia
    Department of Hematology, IRCCS Maggiore Hospital and University of Milan, Milan, Italy
    Leuk Lymphoma 44:1495-501. 2003
    ..We retrospectively analyzed the incidence of thrombotic and infectious complications in relation with the use of central venous catheters (CVCs), in a series of patients with hematological malignancies and low platelet and leucocyte counts...
  39. ncbi European Code Against Cancer and scientific justification: third version (2003)
    P Boyle
    Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:973-1005. 2003
  40. ncbi Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies
    M Colleoni
    Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy
    Ann Oncol 15:1633-9. 2004
    ..While data exist to clearly correlate small tumor size to better prognosis, the fact that very small breast cancers may express biological markers of dire prognosis leads many to ignore small tumor size during treatment decision-making...
  41. pmc Cigarette smoking accelerates progression of alcoholic chronic pancreatitis
    P Maisonneuve
    Epidemiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Gut 54:510-4. 2005
    ..Smoking is a recognised risk factor for pancreatic cancer and has been associated with chronic pancreatitis and also with type II diabetes...
  42. ncbi Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    U Beller
    Int J Gynaecol Obstet 95:S7-27. 2006
  43. ncbi Rationale for a study adding tamoxifen to HRT
    N Rotmensz
    European Institute of Oncology, Milan, Italy
    Eur J Cancer 38:S22-3. 2002
  44. ncbi Epidemiology of pancreatic diseases in L√ľneburg County. A study in a defined german population
    P G Lankisch
    Department of Internal Medicine, Municipal Clinic of Luneburg, Germany
    Pancreatology 2:469-77. 2002
    ..Worldwide, the incidence of pancreatic cancer is very well known, that of acute pancreatitis and chronic pancreatitis not. Our study sought to determine the incidence of all three pancreatic diseases in a well-defined population in Germany...
  45. ncbi Tamoxifen for breast cancer among hysterectomised women
    U Veronesi
    Divisions of Senology, European Institute of Oncology, Milan, Italy
    Lancet 359:1122-4. 2002
    ..So far, no woman has died from breast cancer in this study. Decisions about introduction of tamoxifen to reduce risk of breast cancer remain important and open questions...
  46. ncbi Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study
    J V Parle
    Division of Primary Care, Public and Occupational Health, Birmingham, UK
    Lancet 358:861-5. 2001
    ..2). INTERPRETATION: A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases...
  47. ncbi Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    A P M Heintz
    Int J Gynaecol Obstet 95:S145-60. 2006
  48. doi Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections
    Josiane Pillonel
    Institut de Veille Sanitaire, Departement des Maladies Infectieuses, Saint Maurice, France
    Transfusion 48:1567-75. 2008
    ..The characteristics of recently infected donors, estimates of HIV-1 incidence, and the residual risk of transfusion-transmitted HIV-1 are presented, in both first-time and repeat donors...
  49. ncbi Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    A P M Heintz
    Int J Gynaecol Obstet 95:S161-92. 2006
  50. ncbi Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokers
    M Bellomi
    School of Medicine, University of Milano, 7 Via Festa del Perdono, 20122 Milan, Italy
    Br J Radiol 80:708-12. 2007
    ..7% did not change, 2.5% grew to > 5 mm and were followed yearly In conclusion, prevalent and incident nodules < or =5 mm detected by low-dose CT screening for lung cancer can be safely checked at 1 year intervals...
  51. ncbi Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    H Y S Ngan
    Int J Gynaecol Obstet 95:S193-203. 2006
  52. ncbi Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    W T Creasman
    Int J Gynaecol Obstet 95:S105-43. 2006
  53. ncbi Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    U Beller
    Int J Gynaecol Obstet 95:S29-42. 2006
  54. ncbi Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    M A Quinn
    Int J Gynaecol Obstet 95:S43-103. 2006
  55. ncbi Has blood glucose level measured on admission to hospital in a patient with acute pancreatitis any prognostic value?
    P G Lankisch
    Department of Internal Medicine, Municipal Clinic of Luneburg
    Pancreatology 1:224-9. 2001
    ..Early detection of pancreatic necrosis allows better management of the disease. Contrast-enhanced computed tomography (CT) as the gold standard for detecting pancreatic necrosis is expensive...
  56. pmc Cancer risk before and following organ transplantation
    P Maisonneuve
    Br J Cancer 91:811; author reply 812. 2004
  57. pmc Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma
    G Puppa
    Division of Pathology, CRO National Cancer Institute, Aviano, Italy
    Br J Cancer 96:1118-26. 2007
    ..Our findings suggest that fascin is a useful prognostic marker for colonic adenocarcinomas...
  58. pmc Risk of pancreatic cancer in patients with cystic fibrosis
    P Maisonneuve
    Gut 56:1327-8. 2007
  59. ncbi Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas
    E Maiorano
    Department of Pathological Anatomy, University of Bari, Italy
    Int J Immunopathol Pharmacol 20:779-89. 2007
    ..These data suggest that loss of Numb is implicated in aberrant differentiation programs of salivary gland carcinomas and may serve as a prognostic indicator in patients treated for these neoplasms...
  60. ncbi Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age
    P Lankisch
    Department of Pediatric Oncology, University Hospital Dusseldorf, Dusseldorf, Germany
    Pediatr Blood Cancer 46:767-72. 2006
    ..The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients...